Table 3.

Transplantation outcomes: univariate analysis

	2 years
	Relapse	NRM	LFS	OS	GRFS
De novo AML	46.3% (42-50.4)	23.8% (20.3-27.4)	30% (26.1-33.9)	33.5% (29.4-37.6)	23.8% (20.3-27.6)
sAML	28.8% (20.9-37.1)	38.7% (30-47.3)	32.5% (24.3-41)	34.4% (25.9-43.1)	25% (17.6-33.1)
P value	.001	.001	.58	.35	.49

	180 days		2 years
	aGVHD grade 2-4	aGVHD grade 3-4	cGVHD	Ext. cGVHD
De novo AML	26.9% (23.3-30.6)	10.4% (8-13.1)	20.7% (17.3-24.3)	10.3% (7.9-13.1)
sAML	20% (13.5-27.4)	8.9% (4.7-14.7)	25.3% (17.7-33.5)	12.5% (7.2-19.4)
P value	.12	.61	.27	.46

Ext, extensive.